EichorEICHOR
Study identifier: NCT06454240 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Completed

A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

Condition: Chronic Rhinosinusitis With Nasal Polyps  ·  Sponsor: Sanofi

PhasePhase 2
Planned participants79
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

This is a parallel, Phase 2, 2-arm, multicenter, randomized, double-blind, placebo-controlled, proof-of-concept study for treatment of CRSwNP. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous lunsekimig in adult participants (aged 18 to 70 years, inclusive) with CRSwNP who are inadequately controlled on intranasal corticosteroid treatment. Participants with and without co-morbid asthma will be included in the study, and lung function will be assessed in both groups. The study duration will be up to approximately 40 weeks per participant, including 4 weeks of screening run-in period, 24 weeks of intervention period, and 12 weeks of follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (29)

Allergy & Rheumatology- Site Number : 8400005La Jolla, California, United States
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400003Roseville, California, United States
Senta Clinic- Site Number : 8400025San Diego, California, United States
James A Haley Veterans' Hospital- Site Number : 8400015Tampa, Florida, United States
Emory University Hospital Midtown- Site Number : 8400012Atlanta, Georgia, United States
The Allergy Group - Asthma & Allergy Boise- Site Number : 8400002Boise, Idaho, United States
Harvard Medical School - Brigham and Women's Hospital Site Number : 8400016Boston, Massachusetts, United States
Essential Medical Research- Site Number : 8400020Tulsa, Oklahoma, United States
McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017Bellaire, Texas, United States
Gary Gross Pharmaceutical Research & Consulting, Inc. Site Number : 8400004Dallas, Texas, United States
Berkson Medical - McKinney- Site Number : 8400014McKinney, Texas, United States
Alamo ENT Associates Site Number : 8400001San Antonio, Texas, United States

+ 17 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →